Accumulating evidence has established that IL-6 plays a pivotal role in cancer-associated inflammation, and overexpression of IL-6 in the tumor site and increased circulating level of IL-6 are related with poor clinical prognosis in multiple types of cancer (14–16). This evidence concerns the gene IL6 and cancer.